Loading...

Zimmer Biomet Holdings, Inc. Peer Comparison

Metric Value Ranking
Market Cap $24.9 Billion 6/16 ABT
$183.8B
SYK
$127.2B
MDT
$113.7B
BSX
$109.6B
EW
$54.3B
ZBH
$24.9B
BRKR
$11.0B
BIO
$8.4B
GKOS
$5.6B
ITGR
$4.0B
CNMD
$2.3B
NUVA
$2.1B
OFIX
$567.1M
SRDX
$486.0M
LUNG
$351.3M
CVRX
$174.5M
Gross Margin 62% 10/16 CVRX
85%
GKOS
77%
EW
76%
SRDX
75%
LUNG
75%
NUVA
72%
BSX
70%
OFIX
68%
MDT
66%
ZBH
62%
SYK
61%
ABT
56%
CNMD
55%
BIO
53%
BRKR
50%
ITGR
27%
Profit Margin 9% 7/16 BRKR
24%
EW
22%
ABT
16%
MDT
16%
SYK
15%
BSX
14%
ZBH
9%
ITGR
6%
CNMD
6%
NUVA
2%
SRDX
1%
OFIX
-11%
BIO
-24%
GKOS
-45%
LUNG
-73%
CVRX
-81%
EBITDA margin 30% 2/16 EW
33%
ZBH
30%
ABT
26%
SYK
24%
NUVA
19%
MDT
18%
ITGR
17%
BRKR
12%
CNMD
11%
SRDX
9%
OFIX
-7%
BIO
-14%
BSX
-15%
GKOS
-29%
CVRX
-74%
LUNG
-75%
Quarterly Revenue $1.9 Billion 6/16 BIO
$2.7T
ABT
$10.2B
MDT
$8.1B
SYK
$5.2B
BSX
$3.7B
ZBH
$1.9B
EW
$1.6B
BRKR
$854.5M
ITGR
$413.2M
NUVA
$317.8M
CNMD
$312.3M
OFIX
$200.4M
GKOS
$82.4M
SRDX
$32.0M
LUNG
$18.9M
CVRX
$11.3M
Quarterly Earnings $172.4 Million 7/16 ABT
$1.6B
MDT
$1.3B
SYK
$788.0M
BSX
$505.0M
EW
$351.9M
BRKR
$205.5M
ZBH
$172.4M
ITGR
$26.4M
CNMD
$19.7M
NUVA
$7.4M
SRDX
$247,000
CVRX
-$9.2M
LUNG
-$13.7M
OFIX
-$22.2M
GKOS
-$36.8M
BIO
-$636.3B
Quarterly Free Cash Flow $78.4 Million 5/16 BIO
$218.1B
MDT
$2.1B
BSX
$779.0M
BRKR
$174.0M
ZBH
$78.4M
SYK
$37.0M
CNMD
$27.1M
ITGR
$17.9M
OFIX
$17.1M
SRDX
$6.1M
ABT
-$0
LUNG
-$0
NUVA
-$495,000
CVRX
-$8.0M
GKOS
-$14.9M
EW
-$138.8M
Trailing 4 Quarters Revenue $5.7 Billion 7/16 BIO
$2.7T
ABT
$40.1B
MDT
$32.3B
SYK
$21.0B
BSX
$14.2B
EW
$6.1B
ZBH
$5.7B
BRKR
$3.0B
ITGR
$1.9B
CNMD
$1.3B
NUVA
$1.2B
OFIX
$746.6M
GKOS
$314.7M
SRDX
$143.0M
LUNG
$53.7M
CVRX
$39.3M
Trailing 4 Quarters Earnings $544.8 Million 6/16 BIO
$2.7T
ABT
$10.2B
MDT
$8.1B
SYK
$5.2B
BSX
$3.7B
ZBH
$1.9B
EW
$1.6B
BRKR
$854.5M
ITGR
$413.2M
NUVA
$317.8M
CNMD
$312.3M
OFIX
$200.4M
GKOS
$82.4M
SRDX
$32.0M
LUNG
$18.9M
CVRX
$11.3M
Quarterly Earnings Growth -26% 14/16 CNMD
984%
NUVA
925%
BSX
261%
BRKR
111%
SRDX
103%
ABT
54%
ITGR
45%
SYK
33%
LUNG
13%
CVRX
13%
MDT
8%
EW
3%
GKOS
-17%
ZBH
-26%
OFIX
-214%
BIO
-76977%
Annual Earnings Growth 445% 1/16 ZBH
445%
SRDX
228%
BSX
141%
MDT
68%
SYK
47%
ITGR
37%
LUNG
24%
BRKR
18%
ABT
7%
CNMD
1%
CVRX
-3%
EW
-8%
GKOS
-18%
NUVA
-50%
OFIX
-286%
BIO
-190324%
Quarterly Revenue Growth 3% 14/16 BIO
365409%
OFIX
64%
CVRX
58%
LUNG
30%
BRKR
21%
SRDX
18%
GKOS
16%
BSX
15%
ITGR
11%
SYK
10%
EW
9%
CNMD
6%
MDT
5%
ZBH
3%
NUVA
2%
ABT
1%
Annual Revenue Growth -22% 16/16 BIO
96242%
OFIX
61%
CVRX
53%
SRDX
40%
ITGR
35%
CNMD
20%
BRKR
13%
BSX
12%
EW
12%
GKOS
10%
MDT
6%
NUVA
4%
SYK
3%
ABT
-3%
LUNG
-12%
ZBH
-22%
Cash On Hand $393.0 Million 6/16 SYK
$2.3B
MDT
$1.6B
EW
$1.2B
BSX
$865.0M
BRKR
$488.3M
ZBH
$393.0M
GKOS
$93.5M
CVRX
$90.6M
NUVA
$80.7M
LUNG
$70.2M
CNMD
$33.9M
OFIX
$33.1M
SRDX
$33.0M
ITGR
$23.7M
BIO
-$0
ABT
-$7.0B
Short Term Debt $970.0 Million 4/16 BIO
$40.9B
SYK
$2.1B
MDT
$1.0B
ZBH
$970.0M
BSX
$531.0M
NUVA
$360.8M
BRKR
$121.2M
EW
$24.8M
ITGR
$8.7M
LUNG
$5.2M
OFIX
$2.0M
SRDX
$1.0M
CNMD
$692,000
CVRX
$231,000
ABT
-$0
GKOS
-$0
Long Term Debt $4.8 Billion 5/16 BIO
$1.4T
MDT
$24.1B
SYK
$10.8B
BSX
$8.6B
ZBH
$4.8B
BRKR
$1.2B
CNMD
$990.1M
ITGR
$959.9M
EW
$597.2M
NUVA
$545.4M
GKOS
$383.7M
OFIX
$111.6M
LUNG
$32.7M
CVRX
$30.4M
SRDX
$29.5M
ABT
$0
PE 45.78 3/16 NUVA
73.28
BSX
68.80
ZBH
45.78
ITGR
43.98
EW
38.41
SYK
37.85
ABT
32.11
CNMD
28.24
MDT
27.07
BRKR
25.79
SRDX
12.12
GKOS
-1.00
BIO
-1.00
OFIX
-1.00
LUNG
-1.00
CVRX
-1.00
PS 4.38 8/16 GKOS
17.67
EW
8.84
BSX
7.70
LUNG
6.54
SYK
6.07
ABT
4.58
CVRX
4.44
ZBH
4.38
BRKR
3.72
MDT
3.52
SRDX
3.40
ITGR
2.10
CNMD
1.84
NUVA
1.70
OFIX
0.76
BIO
0.00
PB 1.98 13/16 GKOS
12.04
BRKR
7.90
EW
7.56
SYK
6.64
BSX
5.61
SRDX
3.92
LUNG
3.18
CNMD
2.72
ITGR
2.61
NUVA
2.34
CVRX
2.30
MDT
2.19
ZBH
1.98
OFIX
0.95
ABT
0.00
BIO
0.00
PC 63.46 5/16 ITGR
168.41
BSX
126.71
MDT
70.06
CNMD
68.69
ZBH
63.46
GKOS
59.50
SYK
54.61
EW
44.34
NUVA
25.83
BRKR
22.57
OFIX
17.13
SRDX
14.71
LUNG
5.01
CVRX
1.93
BIO
-1.00
ABT
-26.08
Liabilities to Equity 0.70 9/16 BRKR
2.04
CNMD
1.70
NUVA
1.34
SYK
1.06
GKOS
1.04
ITGR
0.93
BSX
0.81
MDT
0.75
ZBH
0.70
OFIX
0.55
CVRX
0.52
LUNG
0.49
SRDX
0.47
BIO
0.41
EW
0.36
ABT
0.00
ROA 0.03 8/16 SRDX
22%
EW
15%
BRKR
10%
SYK
9%
BSX
5%
MDT
5%
CNMD
4%
ZBH
3%
ITGR
3%
NUVA
1%
GKOS
-14%
OFIX
-16%
LUNG
-27%
CVRX
-36%
BIO
-43%
ABT
-100%
ROE 0.04 10/16 SRDX
32%
BRKR
31%
EW
20%
SYK
18%
ABT
15%
CNMD
10%
BSX
8%
MDT
8%
ITGR
6%
ZBH
4%
NUVA
3%
BIO
-7%
OFIX
-25%
GKOS
-29%
LUNG
-41%
CVRX
-54%
Current Ratio 2.42 6/16 EW
3.82
SRDX
3.11
LUNG
3.04
CVRX
2.93
OFIX
2.83
ZBH
2.42
MDT
2.34
BSX
2.25
ITGR
2.08
GKOS
1.96
SYK
1.95
NUVA
1.75
CNMD
1.59
BRKR
1.49
BIO
0.41
ABT
-1.00
Quick Ratio 0.04 12/16 NUVA
73.28
BSX
68.80
ZBH
45.78
ITGR
43.98
EW
38.41
SYK
37.85
ABT
32.11
CNMD
28.24
MDT
27.07
BRKR
25.79
SRDX
12.12
GKOS
-1.00
BIO
-1.00
OFIX
-1.00
LUNG
-1.00
CVRX
-1.00
Long Term Debt to Equity 0.38 10/16 CNMD}
1.16
GKOS}
0.83
BRKR}
0.83
ITGR}
0.63
NUVA}
0.61
SYK}
0.56
MDT}
0.47
BSX}
0.44
CVRX}
0.40
ZBH}
0.38
LUNG}
0.30
SRDX}
0.24
OFIX}
0.19
BIO}
0.16
EW}
0.08
ABT}
0.00
Debt to Equity 0.46 9/16 CNMD
1.16
NUVA
1.02
BRKR
0.92
GKOS
0.83
ITGR
0.69
SYK
0.56
MDT
0.49
BSX
0.47
ZBH
0.46
CVRX
0.40
LUNG
0.34
SRDX
0.27
OFIX
0.19
BIO
0.16
EW
0.10
ABT
0.00
Burn Rate 1.49 9/16 SRDX
27.93
SYK
14.67
CVRX
8.68
ABT
4.42
LUNG
4.29
GKOS
1.79
CNMD
1.69
ITGR
1.67
ZBH
1.49
OFIX
1.22
NUVA
0.77
BIO
0.00
BRKR
-3.79
EW
-3.81
MDT
-16.09
BSX
-29.41
Cash to Cap 0.02 7/16 CVRX
0.52
LUNG
0.20
SRDX
0.07
OFIX
0.06
BRKR
0.04
NUVA
0.04
ZBH
0.02
GKOS
0.02
EW
0.02
SYK
0.02
BSX
0.01
MDT
0.01
ITGR
0.01
CNMD
0.01
BIO
0.00
ABT
-0.04
CCR 0.45 8/16 SRDX
24.87
MDT
1.61
BSX
1.54
CNMD
1.37
CVRX
0.87
BRKR
0.85
ITGR
0.68
ZBH
0.45
GKOS
0.40
SYK
0.05
ABT
0.00
LUNG
0.00
NUVA
-0.07
BIO
-0.34
EW
-0.39
OFIX
-0.77
EV to EBITDA 53.72 9/16 SRDX}
176.63
BRKR}
114.13
SYK}
109.80
EW}
102.16
CNMD}
93.75
MDT}
92.56
ITGR}
72.95
ABT}
71.62
ZBH}
53.72
NUVA}
47.54
BIO}
-3.78
CVRX}
-13.61
LUNG}
-22.55
OFIX}
-44.37
BSX}
-206.73
GKOS}
-247.22
EV to Revenue 5.33 6/16 GKOS
18.59
EW
8.75
BSX
8.28
SYK
6.47
LUNG
5.94
ZBH
5.33
ABT
4.76
MDT
4.25
BRKR
3.98
SRDX
3.40
CVRX
2.91
ITGR
2.64
CNMD
2.60
NUVA
2.37
OFIX
0.87
BIO
0.53